SARS-CoV-2 Spike RBD (Bebtelovimab biosimilar) Neutralizing Antibody, Unconjugated, Human
Artikelnummer:
RDD-RD90430A
| Artikelname: |
SARS-CoV-2 Spike RBD (Bebtelovimab biosimilar) Neutralizing Antibody, Unconjugated, Human |
| Artikelnummer: |
RDD-RD90430A |
| Hersteller Artikelnummer: |
RD90430A |
| Alternativnummer: |
RDD-RD90430A-200,RDD-RD90430A-100 |
| Hersteller: |
reddot Biotech |
| Wirt: |
Human |
| Kategorie: |
Antikörper |
| Applikation: |
ELISA |
| Spezies Reaktivität: |
Virus |
| Konjugation: |
Unconjugated |
| Alternative Synonym: |
RBD, SARS-CoV-2 Surface Glycoprotein, Spkie protein, sars-cov-2 |
| This is a SARS-CoV-2 Spike RBD (Bebtelovimab biosimilar) Neutralizing Virus Antibody from Reddot Biotech. This product is for Research Use Only. |
| Konzentration: |
1 mg/mL |
| Puffer: |
PBS,pH7.4 |
| Reinheit: |
Protein A purification |
| Application Verdünnung: |
ELISA 1:5000-1:10000 |
![]()
|
Immobilized Recombinant SARS-CoV-2 Spike RBD Protein (N-His Tag)(Omicron) at 2.0 ug/mL (100 uL/well) can bind SARS-CoV-2 Spike RBD (Bebtelovimab biosimilar) Neutralizing Antibody, the EC50 is 0.1121 ug/mL. |
![]()
|
Antibodies from Reddot Biotech |
